WHAT IS KOSELUGO?

Koselugo is the FIRST and ONLY FDA-approved treatment shown to reduce the size of plexiform neurofibromas (PN)*

Koselugo bottles with tablets outside

 

Find out about the experiences of patients who took Koselugo in a clinical study Learn more

 

KOSELUGO HAS BEEN SHOWN TO SHRINK TUMORS IN CHILDREN AGED 2 YEARS AND OLDER

In a clinical study, Koselugo was proven to work for children with NF1 and plexiform neurofibromas (PN):

66% Pie Chart

66% of patients saw their plexiform neurofibromas (PN) shrink*

82% of patients who responded continued to benefit for at least one year.

 

What did people taking Koselugo treatment experience in a clinical study? Learn more

 

*Patients saw a 20% or more decrease in the size of their plexiform neurofibromas, confirmed by 3D magnetic resonance imaging scan.

NF1=neurofibromatosis type 1.

Important Safety Inforamtion